Treatment for Trichotillomania
Behavioral therapy with habit-reversal training (BT-HRT) is the first-line treatment for trichotillomania, demonstrating superior efficacy over all pharmacological interventions with a large effect size (SMD = -1.22). 1
First-Line Treatment Approach
Behavioral Therapy with Habit-Reversal Training
- BT-HRT should be initiated as the primary treatment modality, showing significantly greater reduction in hair-pulling behavior compared to supportive therapy and all medication options 2, 3, 1
- Group cognitive-behavioral therapy format is effective, with 22 sessions demonstrating significant improvement in hair-pulling behavior as measured by the Massachusetts General Hospital Hairpulling Scale 2
- BT-HRT produces effect sizes approximately twice as large as clomipramine (ES = -1.14 vs -0.68) and substantially larger than SSRIs 3
When Behavioral Therapy Alone is Insufficient
If patients do not demonstrate significant improvement after 12 weeks of behavioral therapy, or if they are unwilling or unable to comply with behavioral interventions, pharmacotherapy should be added 4, 5
Pharmacological Treatment Algorithm
First-Line Pharmacotherapy: N-Acetylcysteine
- N-acetylcysteine is the preferred first-line medication due to significant benefits (SMD = -0.75) and low risk of side effects 5, 1
- This glutamate-modulating agent is particularly appropriate when behavioral therapy is not feasible or as augmentation to ongoing behavioral treatment 5
Second-Line Pharmacotherapy: Clomipramine
- Clomipramine demonstrates moderate efficacy (SMD = -0.71) and is superior to placebo 3, 1
- This tricyclic antidepressant should be considered when N-acetylcysteine proves insufficient 5
Alternative Pharmacotherapy: Olanzapine
- Olanzapine shows significant benefit (SMD = -0.94) in single randomized trials 1
- Consider this atypical antipsychotic when other agents have failed, though monitor carefully for metabolic side effects 1
Medications to Avoid
- SSRIs (including sertraline) as monotherapy show no evidence of efficacy over placebo (ES = 0.02) and should not be used as single-agent treatment 3, 1
Optimal Treatment Strategy: Combined Modality
The combination of sertraline plus habit-reversal training produces larger gains and higher responder rates than either modality alone, making dual treatment the most effective approach for patients who can tolerate both interventions 4
- Patients receiving combined treatment are much more likely to reach responder status at final evaluation compared to single modality treatment 4
- This combination approach should be implemented when initial behavioral therapy shows inadequate response after 12 weeks 4
Critical Clinical Considerations
Interdisciplinary Approach Required
- Trichotillomania requires comprehensive treatment planning with psychiatry-dermatology liaison and concurrent support services 5
- Physicians must maintain a nonjudgmental, empathic, and inviting attitude, as patients often deny the habit 5
Social Support is Essential
- Social support is a significant pillar to successful habit-reversal training 5
- In pediatric cases, parents must be educated that negative feedback and punishment for hair pulling will not produce positive results 5
- Familial support is crucial to achieving remission 5
Diagnostic Confirmation
- Trichoscopy reveals abnormalities from stretching and fracture of hair shafts 5
- Biopsy may be necessary if patients or parents have difficulty accepting the self-inflicted nature of the diagnosis 5
- The condition typically presents with bizarre pattern nonscarring patchy alopecia with short hair and negative pull test 5
Common Pitfalls to Avoid
- Do not use SSRI monotherapy as there is no evidence of efficacy over placebo 3, 1
- Avoid relying solely on pharmacotherapy when behavioral therapy is available, as BT-HRT demonstrates substantially larger treatment effects 3, 1
- Do not dismiss the importance of addressing comorbidities such as depression, anxiety, and social maladjustment, which often coexist with trichotillomania 2
- Recognize that trichotillomania is classified as an obsessive-compulsive related disorder, not an impulse control disorder, which informs treatment selection 6